Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FOLD | AMGN | REGN | VRTX | GILD |
| Company | Amicus Therapeutics | Amgen Inc | Regeneron Pharmaceuticals | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 10.03 | 316.66 | 1,007.46 | 460.00 | 85.18 |
| High | 10.19 | 322.99 | 1,014.63 | 468.16 | 86.85 |
| Low | 9.90 | 314.70 | 1,001.00 | 456.16 | 85.06 |
| Last | 10.16 | 322.41 | 1,012.19 | 467.97 | 86.14 |
| Change | +0.12 | +4.73 | +6.93 | +9.03 | +0.93 |
| % Change | +1.20% | +1.49% | +0.69% | +1.97% | +1.09% |
| Volume | 1,265,100 | 1,379,400 | 598,300 | 1,007,000 | 6,162,100 |
| 20-Day Average Volume | 2,309,190 | 2,060,315 | 717,370 | 1,006,040 | 7,556,955 |
| Previous Close | 10.04 | 317.68 | 1,005.26 | 458.94 | 85.21 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.82 | 325.75 | 1,074.14 | 467.19 | 83.88 |
| 20-Day Raw Stochastic | 17.38% | 37.95% | 10.91% | 47.75% | 86.64% |
| 20-Day Relative Strength | 36.94% | 48.11% | 34.32% | 49.10% | 70.90% |
| Weighted Alpha | -7.90 | +14.39 | +15.52 | +23.41 | +19.06 |
| Today's Opinion | 56% Sell | 40% Buy | 8% Sell | 8% Buy | 100% Buy |
| Previous Opinion | 56% Sell | 24% Buy | 8% Sell | 8% Buy | 88% Buy |
| Last Month's Opinion | 24% Buy | 88% Buy | 80% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.06% since 10/02/24 | +0.84% since 10/02/24 | -2.70% since 10/02/24 | +1.26% since 10/02/24 | +1.65% since 10/02/24 |
| Low | 9.90 on 10/09/24 | 314.70 on 10/09/24 | 992.79 on 10/07/24 | 447.70 on 10/07/24 | 83.98 on 10/04/24 |
| High | 10.68 on 10/04/24 | 322.99 on 10/09/24 | 1,038.81 on 10/03/24 | 468.16 on 10/09/24 | 86.85 on 10/09/24 |
| 1-Month | |||||
| %Chg | -11.73% since 09/09/24 | -1.08% since 09/09/24 | -11.58% since 09/09/24 | -0.67% since 09/09/24 | +8.80% since 09/09/24 |
| Low | 9.90 on 10/09/24 | 312.16 on 09/25/24 | 992.79 on 10/07/24 | 447.70 on 10/07/24 | 78.73 on 09/10/24 |
| High | 11.51 on 09/10/24 | 339.17 on 09/23/24 | 1,170.58 on 09/13/24 | 490.15 on 09/16/24 | 86.85 on 10/09/24 |
| 3-Month | |||||
| %Chg | -1.45% since 07/09/24 | +2.06% since 07/09/24 | -3.97% since 07/09/24 | -3.71% since 07/09/24 | +27.13% since 07/09/24 |
| Low | 9.35 on 08/05/24 | 306.59 on 08/07/24 | 992.79 on 10/07/24 | 447.70 on 10/07/24 | 67.65 on 07/10/24 |
| High | 12.19 on 08/21/24 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 86.85 on 10/09/24 |
| 6-Month | |||||
| %Chg | -13.53% since 04/09/24 | +19.25% since 04/09/24 | +7.24% since 04/09/24 | +15.70% since 04/09/24 | +23.16% since 04/09/24 |
| Low | 9.02 on 05/13/24 | 260.68 on 04/19/24 | 875.22 on 04/26/24 | 391.01 on 04/18/24 | 62.07 on 05/31/24 |
| High | 12.19 on 08/21/24 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 86.85 on 10/09/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,973,838 | 170,414,656 | 110,765,568 | 118,430,848 | 106,159,136 |
| Shares Outstanding, K | 296,199 | 536,435 | 110,186 | 258,053 | 1,245,853 |
| Annual Sales | 399,360,000 | 28,190,000,000 | 13,117,200,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -151,580,000 | 6,717,000,000 | 3,953,600,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 126,670,000 | 8,388,000,000 | 3,547,100,000 | 2,645,600,000 | 6,954,000,000 |
| Last Quarter Net Income | -15,700,000 | 746,000,000 | 1,432,300,000 | -3,593,600,000 | 1,614,000,000 |
| 60-Month Beta | 0.69 | 0.61 | 0.12 | 0.40 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.06 on 08/08/24 | 4.97 on 08/06/24 | 11.56 on 08/01/24 | -12.83 on 08/01/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 11/13/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/07/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | N/A | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.07 | 25.93 | 0.00 | 17.96 |